Perceptive Advisors LLC
- SEC CIK
- 0001224962
- 最新申報
- 2026/8/14
2021 年第 2 季持倉
持倉截至 2021/6/30，2021/8/17 申報。只含多頭部位，變化是跟 2021 年第 1 季比股數。
- 持股檔數
- 148
- 較 2021 年第 1 季 +12
- 總值
- $76.9 億
- 較 2021 年第 1 季 +$1.66 億 (+2.2%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| VRCAVerrica Pharmaceuticals Inc. | COM | 3,610,412 | $4,080 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 661,162 | $4,179 萬 | 0.5% | +661,162 | 新進 | 歷史 |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 7,695,505 | $4,202 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| CMAXCareMax, Inc. | COM CL A | 3,320,000 | $4,283 萬 | 0.6% | +3,320,000 | 新進 | 歷史 |
| Coherus Biosciences Inc19249HAB9 | NOTE 1.500% 4/1 | – | $4,605 萬 | 0.6% | – | 新進 | – |
| AVIRAtea Pharmaceuticals, Inc. | COM | 2,259,224 | $4,853 萬 | 0.6% | −850,000−27.3% | 減碼 | 歷史 |
| SLDBSolid Biosciences Inc. | COM | 13,412,552 | $4,909 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 938,140 | $5,384 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| MDTMedtronic plc | Stock | 450,000 | $5,586 萬 | 0.7% | +450,000 | 新進 | 歷史 |
| MGNXMacrogenics Inc | COM | 2,148,060 | $5,770 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| QTNTQuotient Ltd | SHS | 16,200,818 | $5,897 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| KRONKronos Bio, Inc. | COM | 2,528,052 | $6,055 萬 | 0.8% | −252,045−9.1% | 減碼 | 歷史 |
| KDMNKadmon Holdings, Inc. | COM | 15,711,334 | $6,080 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 700,408 | $6,117 萬 | 0.8% | −286,879−29.1% | 減碼 | 歷史 |
| ATNXAthenex, Inc. | COM | 13,532,467 | $6,252 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| CHRSCoherus Oncology, Inc. | COM | 4,697,612 | $6,497 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| ZYZymergen Inc. | COM | 1,633,332 | $6,535 萬 | 0.8% | +1,633,332 | 新進 | 歷史 |
| BEAMBeam Therapeutics Inc. | COM | 537,635 | $6,920 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 2,018,097 | $7,384 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 3,963,517 | $7,471 萬 | 1.0% | +304,136+8.3% | 加碼 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 2,475,660 | $7,870 萬 | 1.0% | −1,821−0.1% | 減碼 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 811,832 | $7,901 萬 | 1.0% | −130,000−13.8% | 減碼 | 歷史 |
| RXDXPrometheus Biosciences, Inc. | COM | 3,314,032 | $8,139 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| ALBOAlbireo Pharma, Inc. | COM | 2,360,139 | $8,303 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| OMICSingular Genomics Systems, Inc. | COM | 3,082,870 | $8,472 萬 | 1.1% | +3,082,870 | 新進 | 歷史 |
| CCCCC4 Therapeutics, Inc. | COM STK | 2,258,566 | $8,546 萬 | 1.1% | −900,000−28.5% | 減碼 | 歷史 |
| NAUTNautilus Biotechnology, Inc. | COM | 8,911,151 | $9,000 萬 | 1.2% | +8,911,151 | 新進 | 歷史 |
| MGTXMeiraGTx Holdings plc | COM | 6,948,277 | $1.08 億 | 1.4% | +15,000+0.2% | 加碼 | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 616,802 | $1.11 億 | 1.4% | +441,802+252.5% | 加碼 | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 9,903,879 | $1.12 億 | 1.5% | +1,200,000+13.8% | 加碼 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 4,643,095 | $1.19 億 | 1.5% | 00.0% | 不變 | 歷史 |
| OMOutset Medical, Inc. | COM | 2,387,535 | $1.19 億 | 1.6% | 00.0% | 不變 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 2,751,603 | $1.22 億 | 1.6% | −116,168−4.1% | 減碼 | 歷史 |
| NVRONevro Corp | COM | 818,760 | $1.36 億 | 1.8% | +6,606+0.8% | 加碼 | 歷史 |
| GBTGlobal Blood Therapeutics, Inc. | COM | 4,152,689 | $1.45 億 | 1.9% | −905,953−17.9% | 減碼 | 歷史 |
| ZYMEZymeworks Inc. | COM | 4,305,600 | $1.49 億 | 1.9% | −25,268−0.6% | 減碼 | 歷史 |
| Nevro Corp64157FAC7 | NOTE 2.750% 4/0 | – | $1.56 億 | 2.0% | – | – | – |
| NVTAInvitae Corp | COM | 4,818,801 | $1.63 億 | 2.1% | −541,872−10.1% | 減碼 | 歷史 |
| LABPLandos Biopharma, Inc. | COM | 14,869,915 | $1.72 億 | 2.2% | 00.0% | 不變 | 歷史 |
| VBIVVBI Vaccines Inc/BC | COM NEW | 55,042,465 | $1.84 億 | 2.4% | 00.0% | 不變 | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 1,985,002 | $1.86 億 | 2.4% | −65,000−3.2% | 減碼 | 歷史 |
| Collegium Pharmaceutical, Inc19459JAA2 | NOTE 2.625% 2/1 | – | $1.90 億 | 2.5% | – | – | – |
| FOLDAmicus Therapeutics, Inc. | COM | 23,121,329 | $2.23 億 | 2.9% | +260,000+1.1% | 加碼 | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 10,959,772 | $2.85 億 | 3.7% | +2,307,987+26.7% | 加碼 | 歷史 |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $3.84 億 | 5.0% | – | – | – |
| SWTXSpringWorks Therapeutics, Inc. | COM | 4,849,912 | $4.00 億 | 5.2% | 00.0% | 不變 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 7,756,928 | $4.73 億 | 6.1% | 00.0% | 不變 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 3,185,898 | $5.15 億 | 6.7% | −288,607−8.3% | 減碼 | 歷史 |
選擇權（2 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2021 年第 1 季之後清倉（17 檔）
2021 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 1 季股數 | 2021 年第 1 季市值 | 2021 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| ALLOAllogene Therapeutics, Inc. | COM | 1,143,790 | $4,038 萬 | 0.5% | 歷史 |
| ARNAArena Pharmaceuticals Inc | COM NEW | 575,007 | $3,990 萬 | 0.5% | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 1,410,305 | $3,639 萬 | 0.5% | 歷史 |
| FMTXForma Therapeutics Holdings, Inc. | SHS | 1,250,000 | $3,503 萬 | 0.5% | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 797,404 | $2,936 萬 | 0.4% | 歷史 |
| PCVXVaxcyte, Inc. | COM | 850,000 | $1,679 萬 | 0.2% | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 270,000 | $603.7 萬 | 0.1% | 歷史 |
| VINCVincerx Pharma, Inc. | COM NEW | 300,000 | $579.0 萬 | 0.1% | 歷史 |
| PHRPhreesia, Inc. | COM | 100,000 | $521.0 萬 | 0.1% | 歷史 |
| Deerfield Healthcare Tech Ac244413209 | UNIT 07/16/2025 | 300,000 | $393.0 萬 | 0.1% | – |
| TXMDTherapeuticsMD, Inc. | COM | 2,750,000 | $368.5 萬 | <0.1% | 歷史 |
| VRAYViewRay, Inc. | COM | 751,748 | $327.0 萬 | <0.1% | 歷史 |
| TLISTalis Biomedical Corp | COM | 250,000 | $321.2 萬 | <0.1% | 歷史 |
| Vincerx Pharma, Inc.92731L114 | *W EXP 12/24/202 | 300,000 | $121.2 萬 | <0.1% | – |
| CVMCel Sci Corp | COM PAR NEW | 33,700 | $51.3 萬 | <0.1% | 歷史 |
| SANASana Biotechnology, Inc. | COM | 10,000 | $33.5 萬 | <0.1% | 歷史 |
| Deerfield Healthcare Tech Ac244413100 | COM CL A | 20,000 | $24.2 萬 | <0.1% | – |